Labyrinthopeptins: A New Class of Carbacyclic Lantibiotics
Angewandte Chemie International Edition 49(6): 1151-1154
Article 2010 English
Authors
KM
K. Meindl
TS
Timo Schmiederer
KS
Kathrin Schneider
Abstract
1 min read
A-maze-ing peptides: The structure of the novel lantibiotic labyrinthopeptin A2 (see picture) contains labionin—an unprecedented carbacyclic, posttranslationally modified amino acid. The identification of the biosynthetic gene cluster of labyrinthopeptins was also successful. Labyrinthopeptin A2 revealed a pronounced in vivo efficacy (attenuation of tactile allodynia) in a mouse model of neuropathic pain.
Kate M. J. de Mattos-Shipley, Claudio Greco, David M. Heard, Gemma Hough, Nicholas P. Mulholland, Jean Louis Vincent, Jason Micklefield, Thomas J. Simpson, Christine L. Willis, Russell J. Cox, Andy M. Bailey
Shaobin Hou, Jimmy H. Saw, Kit Shan Lee, Tracey Freitas, Claude Bélisle, Yutaka Kawarabayasi, Stuart P. Donachie, Alla P. Pikina, Michael Y. Galperin, Eugene V Koonin, Kira S. Makarova, Marina V. Omelchenko, Alexander V. Sorokin, Yuri I. Wolf, Qing X. Li, Young Soo Keum, Sonia Campbell, Judith R. Denery, Shin‐Ichi Aizawa, Satoshi Shibata, Alexander Malahoff, M. Shahid Alam
Discussion(0)
No comments yet. Be the first to comment.